Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

NAAS RATING: 5.23 | Free Publication Certificate
updates
NAAS Rating: 5.23 new

Vol. 2, Issue 11 (2014)

Acute Exacerbation of Chronic Obstructive Pulmonary Disease, Caused by Viruses: The need of Combined Anti-Infective Chemotherapy

Author(s):
Ya. О. Dziublyk
Abstract:
The aim of the study was to evaluate the effectiveness of combined antibacterial and anti-viral therapy of patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD), caused by viruses.
Materials and Methods: 56 patients with AECOPD, triggered by acute respiratory viral infection (ARI) were enrolled. All patients were administered amoxicillin/clavulanate 1000 mg twice daily plus vitaglutam 90 mg once daily (1st group) or amoxicillin/clavulanate 1000 mg twice daily (2nd group). All patients were examined using physical and laboratory tests. Biological samples of all patients were also tested in order to identify viral and bacterial pathogens. 
Results: In patients of 1st group we observed shorter use of antibiotic, lower rate of infectious complications and faster clinical and laboratory recovery. The data of pharmacoeconomical analysis indicated that the cost of antimicrobial therapy was lower in the 1st group as well.
Pages: 85-90  |  1422 Views  27 Downloads


The Pharma Innovation Journal
How to cite this article:
Ya. О. Dziublyk. Acute Exacerbation of Chronic Obstructive Pulmonary Disease, Caused by Viruses: The need of Combined Anti-Infective Chemotherapy. Pharma Innovation 2014;2(11):85-90.
Important Publications Links
The Pharma Innovation Journal

The Pharma Innovation Journal

Call for book chapter
The Pharma Innovation Journal